The latest closing stock price for ArriVent BioPharma as of November 20, 2024 is 27.41.
An investor who bought $1,000 worth of ArriVent BioPharma stock at the IPO in 2024 would have $371 today, roughly 0 times their original investment - a 37.05% compound annual growth rate over 1 years.
The all-time high ArriVent BioPharma stock closing price was 35.63 on November 07, 2024.
The ArriVent BioPharma 52-week high stock price is 36.37, which is 32.7% above the current share price.
The ArriVent BioPharma 52-week low stock price is 14.35, which is 47.6% below the current share price.
The average ArriVent BioPharma stock price for the last 52 weeks is 21.91.
An investor who bought $1,000 worth of ArriVent BioPharma stock at the IPO in 2024 would have $371 today, roughly 0 times their original investment - a 37.05% compound annual growth rate over 1 years.
The all-time high ArriVent BioPharma stock closing price was 35.63 on November 07, 2024.
The ArriVent BioPharma 52-week high stock price is 36.37, which is 32.7% above the current share price.
The ArriVent BioPharma 52-week low stock price is 14.35, which is 47.6% below the current share price.
The average ArriVent BioPharma stock price for the last 52 weeks is 21.91.